XTL Biopharmaceutica Financials
| XTLB Stock | ILS 5.80 0.60 11.54% |
XTL |
Understanding current and past XTL Biopharmaceutica Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of XTL Biopharmaceutica's financial statements are interrelated, with each one affecting the others. For example, an increase in XTL Biopharmaceutica's assets may result in an increase in income on the income statement.
Please note, the presentation of XTL Biopharmaceutica's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, XTL Biopharmaceutica's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of XTL Biopharmaceutica's management manipulating its earnings.
XTL Biopharmaceutica Stock Summary
XTL Biopharmaceutica competes with Nice, Gold Bond, Bank Leumi, ICL Israel, and Mizrahi Tefahot. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. XTL BIOPHARMACEUTI is traded on Tel Aviv Stock Exchange in Israel.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0010854979 |
| Business Address | 5 Badner Street, |
| Benchmark | Dow Jones Industrial |
| Website | www.xtlbio.com |
| Phone | 972 3 611 6600 |
| Currency | ILS - Israeli Shekel |
You should never invest in XTL Biopharmaceutica without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of XTL Stock, because this is throwing your money away. Analyzing the key information contained in XTL Biopharmaceutica's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
XTL Biopharmaceutica Key Financial Ratios
XTL Biopharmaceutica's financial ratios allow both analysts and investors to convert raw data from XTL Biopharmaceutica's financial statements into concise, actionable information that can be used to evaluate the performance of XTL Biopharmaceutica over time and compare it to other companies across industries.XTL Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XTL Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare XTL Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XTL Biopharmaceutica competition to find correlations between indicators driving XTL Biopharmaceutica's intrinsic value. More Info.XTL Biopharmaceuticals is rated first in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value XTL Biopharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for XTL Biopharmaceutica's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.XTL Biopharmaceuticals Systematic Risk
XTL Biopharmaceutica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. XTL Biopharmaceutica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on XTL Biopharmaceuticals correlated with the market. If Beta is less than 0 XTL Biopharmaceutica generally moves in the opposite direction as compared to the market. If XTL Biopharmaceutica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one XTL Biopharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of XTL Biopharmaceutica is generally in the same direction as the market. If Beta > 1 XTL Biopharmaceutica moves generally in the same direction as, but more than the movement of the benchmark.
XTL Biopharmaceutica December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of XTL Biopharmaceutica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of XTL Biopharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of XTL Biopharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing XTL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build XTL Biopharmaceutica's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 33.31 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 9.23 |
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |